These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 517240)

  • 1. Molecular mechanisms of surface-dependent activation of Hageman factor (Factor XII).
    Griffin JH; Beretta G
    Adv Exp Med Biol; 1979; 120B():39-51. PubMed ID: 517240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Studies on prekallikrein of bovine plasma. II. Activation of prekallikrein with proteinases and properties of kallikrein activated by bovine Hageman factor.
    Takahashi H; Nagasawa S; Suzuki T
    J Biochem; 1980 Jan; 87(1):23-34. PubMed ID: 6766924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding and cleavage characteristics of human Hageman factor during contact activation. A comparison of normal plasma with plasmas deficient in factor XI, prekallikrein, or high molecular weight kininogen.
    Revak SD; Cochrane CG; Griffin JH
    J Clin Invest; 1977 Jun; 59(6):1167-75. PubMed ID: 864009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of surface in surface-dependent activation of Hageman factor (blood coagulation factor XII).
    Griffin JH
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1998-2002. PubMed ID: 273926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hageman factor substrates. Human plasma prekallikrein: mechanism of activation by Hageman factor and participation in hageman factor-dependent fibrinolysis.
    Mandle R; Kaplan AP
    J Biol Chem; 1977 Sep; 252(17):6097-104. PubMed ID: 408348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Human plasma prekallikrein. Studies of its activation by activated factor XII and of its inactivation by diisopropyl phosphofluoridate.
    Bouma BN; Miles LA; Beretta G; Griffin JH
    Biochemistry; 1980 Mar; 19(6):1151-60. PubMed ID: 6768384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
    Meier HL; Pierce JV; Colman RW; Kaplan AP
    J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of human Hageman factor by a leukocytic protease.
    Newball HH; Revak SD; Cochrane CG; Griffin JH; Lichtenstein LM
    Adv Exp Med Biol; 1979; 120B():139-51. PubMed ID: 517231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conversion of bovine prekallikrein to kallikrein. Evidence of limited proteolysis of prekallikrein by bovine Hageman factor (factor XII).
    Takahashi H; Nagasawa S; Suzuki T
    FEBS Lett; 1972 Jul; 24(1):98-100. PubMed ID: 5086625
    [No Abstract]   [Full Text] [Related]  

  • 10. The autoactivation of rabbit Hageman factor.
    Wiggins RC; Cochrane CC
    J Exp Med; 1979 Nov; 150(5):1122-33. PubMed ID: 501286
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymatic activities of activated and zymogen forms of human Hageman factor (factor XII).
    Silverberg M; Kaplan AP
    Blood; 1982 Jul; 60(1):64-70. PubMed ID: 6979361
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activation of rabbit Hageman factor by homogenates of cultured rabbit endothelial cells.
    Wiggins RC; Loskutoff DJ; Cochrane CG; Griffin JH; Edgington TS
    J Clin Invest; 1980 Jan; 65(1):197-206. PubMed ID: 6444222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Amidolytic properties of single-chain activated Hageman factor.
    Ratnoff OD; Saito H
    Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1461-3. PubMed ID: 286331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Species differences in amino acid sequences of Hageman factor and prekallikrein at region around scissile bond in activation.
    Yamamoto T; Shibuya Y; Semba U
    Immunopharmacology; 1996 May; 32(1-3):34-8. PubMed ID: 8796263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Activation of Hageman factor in solid and fluid phases. A critical role of kallikrein.
    Cochrane CG; Revak SD; Wuepper KD
    J Exp Med; 1973 Dec; 138(6):1564-83. PubMed ID: 4271629
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Surface and fluid phase activities of two forms of activated Hageman factor produced during contact activation of plasma.
    Revak SD; Cochrane CG; Bouma BN; Griffin JH
    J Exp Med; 1978 Mar; 147(3):719-29. PubMed ID: 632748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Direct evidence for Hageman factor (factor XII) activation by bacterial lipopolysaccharides (endotoxins).
    Morrison DC; Cochrane CG
    J Exp Med; 1974 Sep; 140(3):797-811. PubMed ID: 4378413
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Isolation and some properties of Hageman factor and its active fragment from human blood].
    Krizhevskaia IuV; Iarovaia GA; Dotsenko VL; Khvatov VB
    Biokhimiia; 1981 Aug; 46(8):1510-8. PubMed ID: 7272366
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A simple and rapid method to study the association of the contact proteins of blood coagulation.
    Katcher HL; Samuel M; Villanueva GB
    Thromb Res; 1992 Dec; 68(6):443-50. PubMed ID: 1341054
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The bradykinin-forming cascade: a historical perspective.
    Kaplan AP
    Chem Immunol Allergy; 2014; 100():205-13. PubMed ID: 24925400
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.